Ditchcarbon
  • Customers
  1. Organizations
  2. Virbac group
Public Profile
Pharmaceutical Preparation Manufacturing
FR
updated 8 days ago

Virbac group

Company website

Virbac Group, a leading player in the global animal health industry, is headquartered in France and operates extensively across Europe, North America, and Asia. Founded in 1964, the company has established itself as a trusted provider of veterinary products and services, focusing on the health and well-being of companion animals and livestock. Virbac's core offerings include vaccines, pharmaceuticals, and nutritional products, all designed to enhance animal health and productivity. What sets Virbac apart is its commitment to research and development, ensuring innovative solutions tailored to the evolving needs of veterinarians and pet owners alike. With a strong market position, Virbac has achieved notable milestones, including a robust international presence and a diverse product portfolio that reflects its dedication to quality and efficacy in animal care.

DitchCarbon Score

How does Virbac group's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

31

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Virbac group's score of 31 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.

56%

Let us know if this data was useful to you

Virbac group's reported carbon emissions

In 2022, Virbac Group reported carbon emissions of approximately 23,727,000 kg CO2e, all of which fall under Scope 1 emissions. This represents an increase from 2021, when emissions were about 20,814,000 kg CO2e. The company has not disclosed any Scope 2 or Scope 3 emissions data for the years 2021 and 2022, indicating a focus primarily on direct emissions from owned or controlled sources. Historically, in 2014, Virbac's total emissions were reported at about 19,186,000 kg CO2e for Scope 1, alongside 15,014,000 kg CO2e for Scope 2 and 6,818,000 kg CO2e for Scope 3. This earlier data illustrates a broader emissions profile, including significant contributions from both indirect emissions and purchased goods and services. Despite the increase in emissions in recent years, Virbac has not set specific reduction targets or climate pledges, nor have they reported any initiatives under the Science Based Targets initiative (SBTi). The absence of documented reduction targets suggests that the company may be in the early stages of formalising its climate commitments. Overall, while Virbac has made strides in emissions reporting, the lack of comprehensive data and reduction initiatives highlights an opportunity for the company to enhance its climate strategy and align with industry standards for sustainability.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2014202020212022
Scope 1
19,186,000
00,000,000
00,000,000
00,000,000
Scope 2
15,014,000
-
-
-
Scope 3
6,818,000
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Virbac group's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Virbac group is in FR, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Virbac group is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

MSD Animal Health

GB
•
Chemicals nec
Updated 13 days ago

Alk

DK
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Idexx Laboratories

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Elanco

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Ceva Sante Animale

FR
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Hikma Pharmaceuticals

GB
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy